Inhibition of carcinogenesis by tea constituents

Jihyeung Ju1, Gang Lu, Joshua D Lambert

  • 1Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8020, USA.

Insights

Tea consumption shows potential cancer preventive activity, with tea polyphenols like EGCG demonstrating inhibitory effects in animal models. However, human cancer prevention evidence remains inconclusive, requiring further clinical trials.

Area of Science:

  • Oncology
  • Nutritional Science
  • Pharmacology

Background:

  • Tea consumption is increasingly recognized for its potential cancer preventive properties.
  • Numerous animal studies demonstrate the inhibitory effects of tea and its constituents on carcinogenesis.
  • The impact of tea on human cancer incidence requires further investigation.

Purpose of the Study:

  • To review the evidence for tea's cancer preventive activity.
  • To explore the mechanisms of action of tea polyphenols, particularly epigallocatechin gallate (EGCG).
  • To highlight the need for human intervention trials to validate findings.

Main Methods:

  • Review of existing literature on tea and cancer prevention.
  • Analysis of studies investigating tea polyphenol mechanisms in cell cultures and animal models.
  • Identification of research gaps, especially in human studies.

Main Results:

  • In vitro and animal studies show significant anti-carcinogenic effects of tea polyphenols, especially EGCG.
  • Mechanistic studies highlight EGCG's role in inhibiting cancer development.
  • Human data on tea consumption and cancer prevention are limited and inconclusive.

Conclusions:

  • While promising, the cancer preventive effects of tea in humans are not yet definitively established.
  • Further research, particularly human intervention trials, is crucial to confirm tea's role in cancer prevention.
  • Understanding the precise mechanisms in humans is essential for targeted applications.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...